DEMORALIZATION
Clinical trials for DEMORALIZATION explained in plain language.
Never miss a new study
Get alerted when new DEMORALIZATION trials appear
Sign up with your email to follow new studies for DEMORALIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Magic mushroom therapy targets Cancer's hidden toll: despair
Symptom relief Recruiting nowThis early-stage study tests whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy can safely reduce demoralization—a deep sense of hopelessness—in 15 adults with advanced cancer. Participants receive 6 therapy sessions plus one 25 mg dose of ps…
Matched conditions: DEMORALIZATION
Phase: PHASE1 • Sponsor: Gustavo Vazquez • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
LSD shows promise for End-of-Life anxiety in new trial
Symptom relief Recruiting nowThis study tests whether moderate to high doses of LSD can reduce anxiety, depression, and pain in people with advanced, life-limiting illnesses. Sixty participants with a life expectancy of 12 weeks to 2 years will receive either two doses of LSD or a very low dose as a placebo.…
Matched conditions: DEMORALIZATION
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
Magic mushroom therapy tested for End-of-Life distress
Symptom relief Recruiting nowThis study tests whether psilocybin (the active ingredient in magic mushrooms) can help reduce feelings of demoralization in adults with a life expectancy of 2 years or less. About 100 participants will receive either psilocybin or an active control in a triple-blind setup. The g…
Matched conditions: DEMORALIZATION
Phase: PHASE2 • Sponsor: Charles S. Grob, M.D. • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC